These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25056657)

  • 1. Authors' response: bile acids are important in the pathophysiology of IBS.
    Bajor A; Törnblom H; Rudling M; Ung KA; Simrén M
    Gut; 2015 May; 64(5):851-2. PubMed ID: 25056657
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for bile acid diarrhoea in suspected irritable bowel syndrome.
    Aziz I; Kurien M; Sanders DS; Ford AC
    Gut; 2015 May; 64(5):851. PubMed ID: 24870624
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.
    Bajor A; Törnblom H; Rudling M; Ung KA; Simrén M
    Gut; 2015 Jan; 64(1):84-92. PubMed ID: 24727487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peculiarities of the effects of bile acids on atpase activity of the colon mucosa in patients with overweight and irritable bowel syndrome.
    Ferents IM; Bychkova SV; Bychkov MA
    Wiad Lek; 2020; 73(3):574-577. PubMed ID: 32285837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids and dioctyl sodium sulfosuccinate in constipation and irritable colon.
    KING JC
    Am J Gastroenterol; 1961 Jan; 35():50-60. PubMed ID: 13756083
    [No Abstract]   [Full Text] [Related]  

  • 6. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
    Camilleri M; Carlson P; Acosta A; Busciglio I
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.
    Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ
    Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S46-8. PubMed ID: 19300123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pharmacological therapies for the irritable bowel syndrome.
    Maneerattanaporn M; Chang L; Chey WD
    Gastroenterol Clin North Am; 2011 Mar; 40(1):223-43. PubMed ID: 21333909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation.
    Abrahamsson H; Ostlund-Lindqvist AM; Nilsson R; Simrén M; Gillberg PG
    Scand J Gastroenterol; 2008; 43(12):1483-8. PubMed ID: 18788050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.
    Wedlake L; A'Hern R; Russell D; Thomas K; Walters JR; Andreyev HJ
    Aliment Pharmacol Ther; 2009 Oct; 30(7):707-17. PubMed ID: 19570102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: role of bile acids.
    Kalia N; Hardcastle J; Keating C; Grasa L; Keating C; Pelegrin P; Bardhan KD; Grundy D
    Gut; 2008 Jan; 57(1):41-9. PubMed ID: 17675326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the colon oversalted in irritable bowel syndrome?].
    Gebbensleben OH
    Z Gastroenterol; 2014 Feb; 52(2):224-5. PubMed ID: 24526408
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the irritable bowel really irritable?
    Coremans G; Tack J; Vantrappen G; Janssens J; Annese V
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):39-40. PubMed ID: 1756281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: colesevelam effects on faecal bile acids in IBS with diarrhoea.
    Walters JR; Appleby RN
    Aliment Pharmacol Ther; 2015 Apr; 41(7):696-7. PubMed ID: 25736144
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: colesevelam effects on faecal bile acids in IBS with diarrhoea - author's reply.
    Camilleri M
    Aliment Pharmacol Ther; 2015 Apr; 41(7):697. PubMed ID: 25736145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.